Towards a Best Practice Approach in PBPK Modeling: Case Example of Developing a Unified Efavirenz Model Accounting for Induction of CYPs 3A4 and 2B6.
| Autor: | Ke, A1, Barter, Z1, Rowland‐Yeo, K1, Almond, L1 |
|---|---|
| Zdroj: | CPT: Pharmacometrics & Systems Pharmacology. Jul2016, Vol. 5 Issue 7, p367-376. 10p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|